Evidence map›Paper›PMID 40331822›Full record

ArticleJournal of virology2025

How to recover from a bad start: adaptation of HIV-1 transcription start site mutants during serial passaging in culture.

Olga A Nikolaitchik, Akhil Chameettachal, Saiful Islam, Zetao Cheng, Krista Delviks-Frankenberry, Brandon F Keele, Vinay K Pathak, Wei-Shau Hu

Abstract read
In one paragraph

Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Olga A NikolaitchikViral Recombination Section, Frederick, Maryland, USA.ORCID 0009-0005-5753-0365
Akhil ChameettachalViral Recombination Section, Frederick, Maryland, USA.
Saiful IslamViral Recombination Section, Frederick, Maryland, USA.
Zetao ChengViral Recombination Section, Frederick, Maryland, USA.
Krista Delviks-FrankenberryViral Mutation Section, HIV Dynamics and Replication Program, National Cancer Institute at Frederick, Frederick, Maryland, USA.
Brandon F KeeleAIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.ORCID 0000-0002-2381-1151
Vinay K PathakViral Mutation Section, HIV Dynamics and Replication Program, National Cancer Institute at Frederick, Frederick, Maryland, USA.
Wei-Shau HuViral Recombination Section, Frederick, Maryland, USA.ORCID 0000-0001-7733-623X

Funding

WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI BRISCOE, LYNN · 2019 to 2025
$3932.6M
Structural Biology CoreU54AI170855 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI Alan N. Engelman · 2022 to 2026
$36.7M
NCI NIH HHS 75N91019D00024NCI NIH HHS Intramural ResearchNIAID NIH HHS U54 AI170855
6 · The paper itself

Abstract

HIV-1 uses neighboring sequences as transcription start sites and generates multiple unspliced transcripts, including two major transcripts with three guanosines (3G) or one guanosine (1G) at the 5' end. Although only differing by 2-nt, 3G RNA and 1G RNA are functionally distinct. We have previously generated two mutants: the TTG virus mainly expresses 1G RNA, whereas the plusAC virus predominantly expresses 3G RNA. Both mutant viruses are replication-competent but exhibit fitness defects. Here, we passaged the plusAC virus in T cells and characterized the changes near the transcription start sites. We observed the rapid loss of the plusAC virus genotype and the emergence of multiple revertants. All major revertants that dominated the cultures had a 1- to 3-nt deletion that compensated for the dinucleotide insertion in the plusAC virus. These major revertants express more than one major transcript, preferentially package 1G RNA, and have improved replication kinetics compared with the plusAC virus. Most major revertants likely arose through errors during reverse transcription, including misalignments during minus-strand DNA transfer, nucleotide deletion in a homopolymer run, or deletion of a short direct repeat. Additionally, we have determined that a T-to-G substitution near transcription start sites occurs at ~5% per replication cycle by copying the guanosine cap. Converting a base to guanosine through cap copying has been observed in multiple positions, but always directly upstream of a major transcription start site. Taken together, our findings demonstrate the selection pressure for expressing functionally distinct unspliced RNA species to optimize replication fitness.IMPORTANCEHIV-1 unspliced RNA serves as the mRNA to translate Gag/Gag-Pol polyproteins and as the virion genome. HIV-1 produces two major RNA species: 1G RNA is preferentially packaged and 3G RNA is favorably translated, although each transcript can perform both functions. We have previously generated a replication-competent mutant virus that mainly expresses 3G RNA and observed that this mutant has replication fitness defects. We found that the mutant virus improved its replication kinetics after passaging, indicating adaptation. Our analyses showed that, through mutations occurring during DNA synthesis, multiple revertants arose rapidly to replace the input mutant virus. The major revertants regained the ability to generate more than one major transcript and preferentially package 1G RNA. These results highlight the importance of expressing HIV-1 RNA species that serve distinct functions and the ability of HIV-1 to adapt through mutations in the genome.

Indexed as

HIV-1MutationTranscription Initiation SiteHumansReverse TranscriptionRNA, ViralSerial PassageTranscription, GeneticVirus ReplicationRNA, Viralgenome packagingHIVreplication fitnessreverse transcriptionRNAtranscriptiontranscription start sitestranslation

Identifiers

PMID40331822
PMCPMC12172438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.